市場調査レポート
商品コード
1643948

アジア太平洋のゲノムシーケンシング市場:製品別、エンドユーザー別、国別 - 分析と予測(2024年~2033年)

Asia-Pacific Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast, 2024-2033


出版日
発行
BIS Research
ページ情報
英文 72 Pages
納期
1~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.96円
アジア太平洋のゲノムシーケンシング市場:製品別、エンドユーザー別、国別 - 分析と予測(2024年~2033年)
出版日: 2025年01月29日
発行: BIS Research
ページ情報: 英文 72 Pages
納期: 1~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のゲノムシーケンシングの市場規模は、2024年に13億米ドルとなりました。

同市場は、2024年から2033年にかけて18.44%のCAGRで成長し、2033年には59億6,000万米ドルに達すると予測されています。科学者は、ゲノム配列決定として知られるプロセスであるDNAの全塩基配列を決定することによって、生物の全遺伝子構成を解読することができます。遺伝的変異を発見し、それが健康や病気に及ぼす可能性のある影響を理解するには、この手順が必要です。次世代シーケンシング(NGS)技術を用いた出生前および新生児スクリーニングプログラムに対する需要の高まり、遺伝子検査の採用拡大、シーケンシングコストの低下により、アジア太平洋地域のゲノムシーケンシング市場は急速に成長しています。

市場が拡大しているのは、複雑な遺伝子データのより正確で詳細な洞察を提供するロングリードシーケンスの用途が拡大している結果です。さらに、アジア太平洋全域の政府プログラムおよび投資により、ゲノムシーケンシング技術の導入が加速し、医療および科学用途へのアクセスが向上しています。

主要市場統計
予測期間 2024年~2033年
2024年の評価 13億米ドル
2033年の予測 59億6,000万米ドル
CAGR 18.44%

この地域がヘルスケアの進歩と精密医療を優先し続ける中、ゲノムシーケンシングは診断、個別化治療、疾病予防を強化するための重要なツールとして台頭しています。これらの要因によってイノベーションが促進され、消費者のアクセスが拡大し、アジア太平洋におけるゲノムシーケンシング市場の将来が形成されると期待されます。

アジア太平洋のゲノムシーケンシング市場は、シーケンス技術の向上、価格の下落、研究およびヘルスケア業界における遺伝子検査ニーズの増加により急速に拡大しています。プレシジョン・メディシンの重要な構成要素であるゲノムシークエンシングは、生物の全DNA配列を明らかにし、より良い病気の予防、個別の治療計画、診断の強化を促進します。

市場拡大の主な要因の1つは、がん診断、希少疾患の特定、出生前・新生児スクリーニングにおける次世代シーケンシング(NGS)の利用の拡大です。また、複雑な遺伝子データの詳細な理解を提供するロングリードシーケンスの技術も、この分野で普及しつつあります。

シーケンス技術の採用を急ぐため、アジア太平洋の政府はゲノム研究とヘルスケアインフラに多額の投資を行っています。これらのプログラムは、教育機関や非公開会社間の提携とともに、アクセシビリティとイノベーションを強化しています。

当レポートでは、アジア太平洋のゲノムシーケンシング市場について調査し、市場の概要とともに、製品別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 ゲノムシーケンシング市場:業界分析

  • 主な動向:現在および将来の影響評価
  • 規制分析
  • 価値とサプライチェーンの分析

第2章 ゲノムシーケンシング市場:市場力学

  • 影響分析
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第3章 ゲノムシーケンシング市場:将来の展望

  • 特許分析
  • 競合ベンチマーキング
  • 臨床導入の順序
  • 今後の見通し

第4章 ゲノムシーケンシング市場(地域別)

  • 地域別概要
  • 促進要因と抑制要因
  • アジア太平洋
    • 地域概要
    • 市場促進要因
    • 市場抑制要因
    • 製品別
    • エンドユーザー別
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他

第5章 ゲノムシーケンシング市場-競合ベンチマーキングと企業プロファイル

  • 主要戦略と開発
    • パートナーシップ、提携、事業拡大
    • 規制および法的活動
    • 新しいサービス
    • 合併と買収
    • 資金調達活動
  • 企業プロファイル
    • MGI Tech Co., Ltd.

第6章 調査手法

図表

List of Figures

  • Figure 1: Asia-Pacific Genome Sequencing Market, $Billion, 2024, 2028, and 2033
  • Figure 2: Genome Sequencing Market (by Region), $Billion, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Genome Sequencing Market (by End User), $Billion, 2023, 2027, and 2033
  • Figure 4: Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023, 2027, and 2033
  • Figure 5: Key Players' Strategic Priorities
  • Figure 6: Potential Future Directions
  • Figure 7: Companies Utilizing Artificial Intelligence in Genomics
  • Figure 8: Share of Partnerships, Alliances, and Business Expansions vs Other Strategies
  • Figure 9: Some of the Key Partnerships, Alliances, and Business Expansions and their Impact on the Sequencing Market
  • Figure 10: Value and Supply Chain Analysis, Genome Sequencing Market
  • Figure 11: Impact Analysis of Market Dynamics, 2022-2033
  • Figure 12: Genome Sequencing Cost Over Time, 2007-2024
  • Figure 13: Newborn Screening Program of Some of the Countries
  • Figure 14: Some Aspects of Long-Read Sequencing
  • Figure 15: Some of the Genome Sequencing Initiatives
  • Figure 16: Volume of Different Genetic Tests, Size in Base Pairs (bp)
  • Figure 17: Genome Sequencing Market, Patent Analysis (by Year), January 2021-December 2023
  • Figure 18: Genome Sequencing Market, Patent Analysis (by Country), January 2021-December 2023
  • Figure 19: Genome Sequencing Market, Market Share, 2023
  • Figure 20: Clinical Utility of Genome Sequencing
  • Figure 21: Future Outlook for Genome Sequencing
  • Figure 22: China Genome Sequencing Market, $Billion, 2023-2033
  • Figure 23: Japan Genome Sequencing Market, $Billion, 2023-2033
  • Figure 24: Australia Genome Sequencing Market, 2022-2033
  • Figure 25: South Korea Genome Sequencing Market, $Billion, 2023-2033
  • Figure 26: Rest-of-Asia-Pacific Genome Sequencing Market, $Billion, 2023-2033
  • Figure 27: Partnerships, Alliances, and Business Expansions Activities, January 2020-April 2024
  • Figure 28: Regulatory and Legal Activities, January 2020-April 2024
  • Figure 29: New Offerings, January 2020-April 2024
  • Figure 30: Mergers and Acquisitions, January 2020-April 2024
  • Figure 31: Funding Activities, January 2020-April 2024
  • Figure 32: Data Triangulation
  • Figure 33: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Genome Sequencing Market, Market Opportunities
  • Table 3: Current and Future Impact of Trends
  • Table 4: Regulatory Landscape (by Country)
  • Table 5: Output and Approximate Required Disk Space to Store an Instrument Run
  • Table 6: Comparison of Some of the Key Sequencers
  • Table 7: Genome sequencing market (by Region), $Billion, 2023-2033
  • Table 8: Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 9: Asia-Pacific Genome Sequencing Market (by End User), $Billion, 2023-2033
  • Table 10: China Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 11: Japan Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 12: India Genome Sequencing Market, $Billion, 2023-2033
  • Table 13: India Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 14: Australia Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 15: South Korea Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 16: Rest-of-Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 17: Genome Sequencing Market, Key Development Analysis, January 2020-April 2024
目次
Product Code: BHP2488SS

Introduction to Asia-Pacific Genome Sequencing Market

The Asia-Pacific genome sequencing market was valued at $1.30 billion in 2024 and is expected to reach $5.96 billion by 2033, growing at a CAGR of 18.44% between 2024 and 2033. Scientists can decipher an organism's entire genetic composition by determining its entire DNA sequence, a process known as genome sequencing. Finding genetic variations and comprehending their possible effects on health and illness require this procedure. Due to rising demand for prenatal and neonatal screening programs using next-generation sequencing (NGS) technologies, growing adoption of genetic testing, and falling sequencing costs, the genome sequencing market in Asia-Pacific is growing quickly.

The market is growing as a result of long-read sequencing's growing applications, which offer more precise and in-depth insights into complicated genetic data. Furthermore, government programs and investments throughout Asia-Pacific are speeding up the adoption of genome sequencing technologies and improving accessibility for medical and scientific applications.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$1.30 Billion
2033 Forecast$5.96 Billion
CAGR18.44%

As the area continues to prioritize healthcare advancements, and precision medicine, genome sequencing is emerging as a vital tool for enhancing diagnostics, personalized treatments, and disease prevention. These factors are expected to drive innovation and expand consumer access, shaping the future of the genome sequencing market in APAC.

Market Introduction

The market for APAC genome sequencing is expanding quickly due to improvements in sequencing technology, falling prices, and an increase in the need for genetic testing in the research and healthcare industries. A key component of precision medicine, genome sequencing reveals an organism's entire DNA sequence, facilitating better disease prevention, individualized treatment plans, and enhanced diagnostics.

One of the main factors propelling market expansion is the growing use of next-generation sequencing (NGS) in cancer diagnostics, rare disease identification, and prenatal and neonatal screening. Technologies for long-read sequencing, which offer in-depth understanding of intricate genetic data, are also becoming more popular in the area.

To hasten the adoption of sequencing technologies, governments throughout Asia-Pacific are making significant investments in genomic research and healthcare infrastructure. These programs, along with partnerships among educational institutions and private companies, are enhancing accessibility and innovation.

As the region prioritizes advancements in healthcare and precision medicine, the APAC genome sequencing market is poised for sustained growth, transforming medical research and improving patient outcomes.

Market Segmentation

Segmentation 1: by Product

  • Kits
  • Instruments
  • Software

Segmentation 2: by End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Population Sequencing Organizations
  • Research and Academic Institutes
  • Others

Segmentation 3: by Region

  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, funding, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the Asia-Pacific genome sequencing market.

Competitive Strategy: The Asia-Pacific genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the Asia-Pacific genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.

Table of Contents

Executive Summary

Scope and Definition

1 Genome Sequencing Market: Industry Analysis

  • 1.1 Key Trends: Current and Future Impact Assessment
    • 1.1.1 Integration of Artificial Intelligence and Machine Learning in Genome Sequencing
    • 1.1.2 Increasing Partnerships, Alliances, and Business Expansions among Key Players
  • 1.2 Regulatory Analysis
  • 1.3 Value and Supply Chain Analysis

2 Genome Sequencing Market: Market Dynamics

  • 2.1 Impact Analysis
  • 2.2 Market Drivers
    • 2.2.1 Decreasing Cost of Genome Sequencing Enabling High Usage of Genome Sequencing/Testing
    • 2.2.2 Rising Prenatal and New-Born Screening Programs Facilitating the Demand for Next-Generation Sequencing
    • 2.2.3 Expanding Applications of Long-Read Sequencing
    • 2.2.4 Government Investments and Initiatives in Genome Sequencing Projects
  • 2.3 Market Restraints
    • 2.3.1 Data Management Challenges in Genome Sequencing
    • 2.3.2 Genomic Data Disparity in Developing Countries
  • 2.4 Market Opportunities
    • 2.4.1 Emergence of Portable Genome Sequencing Enabling Bedside Testing
    • 2.4.2 Multiomics Shaping the Global Genome Sequencing Landscape

3 Genome Sequencing Market: Future Outlook

  • 3.1 Patent Analysis
    • 3.1.1 Patent Analysis (by Year)
    • 3.1.2 Patent Analysis (by Country)
  • 3.2 Competitive Benchmarking
    • 3.2.1 Market Share
    • 3.2.2 Brand Recognition
  • 3.3 Sequencing Clinical Adoption
  • 3.4 Future Outlook

4 Genome sequencing market (By Region)

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints
  • 4.3 Asia-Pacific
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 By Product
    • 4.3.5 By End User
    • 4.3.6 China
      • 4.3.6.1 By Product
    • 4.3.7 Japan
      • 4.3.7.1 By Product
    • 4.3.8 India
      • 4.3.8.1 By Product
    • 4.3.9 Australia
      • 4.3.9.1 By Product
    • 4.3.10 South Korea
      • 4.3.10.1 By Product
    • 4.3.11 Rest-of-Asia-Pacific
      • 4.3.11.1 By Product

5 Genome sequencing market - Competitive Benchmarking and Company Profiles

  • 5.1 Key Strategies and Development
    • 5.1.1 Partnerships, Alliances, and Business Expansions
    • 5.1.2 Regulatory and Legal Activities
    • 5.1.3 New Offerings
    • 5.1.4 Mergers and Acquisitions
    • 5.1.5 Funding Activities
  • 5.2 Company Profiles
    • 5.2.1 MGI Tech Co., Ltd.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products and Services
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Key Personnel
      • 5.2.1.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation